MUTANTE INTERLEUKIN-2-POLYPEPTIDE
Patent europeic · EP3075745 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP3075745
- Numer da la dumonda
- EP16164244
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 07-02-2012
- Publitgà
- 05-10-2016
- Concedì
- 05-09-2018
- Stritgà
- 24-09-2024
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- C07K 14/55 (2006.01)C12N 15/26 (2006.01)A61K 39/395 (2006.01)C07K 16/46 (2006.01)C07K 19/00 (2006.01)C07K 14/54 (2006.01)A61K 38/20 (2006.01)C07K 16/30 (2006.01)C07K 16/40 (2006.01)A61K 39/00 (2006.01)A61K 47/68 (2017.01)
- Prioritad
- EP 11153964 10.02.2011EP 11164237 29.04.2011
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 24-09-2024
Stritgà, taxa betg pajada
- Status of protective title
- Active → Cancelled
- Cancellation date
- 24.09.2024
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 24.09.2024
- 06-03-2023
Midada
Published in Swissreg on 06.03.2023
- 19-10-2021
Adressa midada
- Owner
- Roche Glycart AG, Wagistrasse 18, 8952 Schlieren → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren
Published in Swissreg on 19.10.2021
- 05-09-2018
Concedì
Published in Swissreg on 05.09.2018
Partidas
Inventur
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.